Form 4: Neogenomics Director Perez Acquires 10,000 Shares
SEC Form 4 Filing
Director David Brian Perez purchased 10,000 shares of Neogenomics Inc. at $7.63 per share on May 5, 2025.
Summary
- On May 5, 2025, David Brian Perez, a director of Neogenomics Inc., acquired 10,000 shares of common stock at a price of $7.63 per share.
- The transaction increased Perez's directly held common stock to 21,636 shares.
- Perez also indirectly owns 10,000 shares through the Perez Joint Revocable Trust.
- Perez also holds derivative securities including stock options and restricted stock units.
Sentiment
Score: 6
Explanation: Insider buying is generally viewed as a positive signal, suggesting confidence in the company's prospects, but it's a single transaction and doesn't guarantee future performance.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. Monitoring such filings can provide insights into management's sentiment towards the company's stock.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/09/2016 | Date of Perez Joint Revocable Trust |
| 06/10/2023 | Exercisable date for stock options at $7.34 |
| 08/10/2024 | Exercisable date for stock options at $14.82 |
| 06/01/2025 | Exercisable date for stock options at $13.71 and restricted stock units |
| 05/05/2025 | Date of stock purchase |
| 05/07/2025 | Date of signature |
| 06/10/2029 | Expiration date for stock options at $7.34 |
| 08/10/2033 | Expiration date for stock options at $14.82 |
| 06/01/2034 | Expiration date for stock options at $13.71 |
Keywords
Neogenomics, Director, Stock Purchase, Insider Trading, Form 4, Share Acquisition, Perez, NEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.